89bio to participate in the bofa securities 2024 health care conference

San francisco, may 08, 2024 (globe newswire) -- 89bio, inc. (nasdaq: etnb), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the company's management will present at the bofa securites 2024 health care conference on wednesday, may 15, 2024 at 2:20 pm pdt and participate in one-on-one investor meetings.
ETNB Ratings Summary
ETNB Quant Ranking